XTX Topco Ltd - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 176 filers reported holding HERON THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.

Quarter-by-quarter ownership
XTX Topco Ltd ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$473,077
+32.8%
407,825
+72.8%
0.08%
+13.3%
Q1 2023$356,321
-58.9%
235,974
-32.0%
0.08%
-59.2%
Q4 2022$867,593
+153.7%
347,037
+327.8%
0.18%
+116.5%
Q3 2022$342,000
+56.9%
81,123
+3.9%
0.08%
-4.5%
Q2 2022$218,000
+86.3%
78,084
+282.1%
0.09%
+74.5%
Q1 2022$117,000
-59.2%
20,436
-23.8%
0.05%
-46.9%
Q3 2021$287,000
+49.5%
26,811
+125.8%
0.10%
+3.2%
Q1 2021$192,00011,8720.09%
Other shareholders
HERON THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
TANG KEVIN C 21,288$250,00019.87%
TANG CAPITAL MANAGEMENT LLC 2,896,904$34,010,0004.78%
PFM Health Sciences, LP 2,481,917$29,138,0002.39%
Iron Triangle Partners LP 500,000$5,870,0002.27%
NEXPOINT ASSET MANAGEMENT, L.P. 777,599$9,129,0001.72%
Pekin Hardy Strauss, Inc. 588,732$6,912,0001.55%
First Light Asset Management, LLC 691,400$8,117,0001.39%
Congress Park Capital LLC 111,045$1,304,0001.18%
Mesirow Financial Investment Management, Inc. 15,135$178,0001.12%
Elk Creek Partners, LLC 509,174$5,978,0001.03%
View complete list of HERON THERAPEUTICS INC shareholders